Outcome of operation in patients with adrenocortical cancer invading the inferior vena cava—a European Society of Endocrine Surgeons (ESES) survey
Authors:
- Radu MihaiRMRadu Mihai
- Maurizio IacoboneMaurizio Iacobone
- Ozer MakayOMOzer Makay
- Pablo MorenoPMPablo Moreno
- Andrea FrillingAFAndrea Frilling
- Jean-Louis KraimpsJKJean-Louis Kraimps
- Arturo SorianoASArturo Soriano
- Jesús Villar del MoralJMJesús Villar del Moral
- Marcin BarczynskiMBMarcin Barczynski
- Manuel C. DuránMDManuel C. Durán
- Gregory P. SadlerGSGregory P. Sadler
- Bruno NiederleBNBruno Niederle
- 2 December 2011
- journal article
- research article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 397 (2) , 225-231
Abstract
Most patients with adrenocortical cancer (ACC) continue to present with advanced disease. Invasion into the inferior vena cava (IVC) defines stage III disease and the management of such patients raises additional difficulties. A multicentre survey was organized by emailing a standardized proforma to members of the European Society of Endocrine Surgery (ESES). Anonymised retrospective clinical data were collected. Replies were received from 18 centres in nine countries. ACC with IVC invasion was encountered in 38 patients (18F:20M, age 15-84 years, median 54 years). There were 16 nonfunctioning tumours and 22 functioning tumours predominantly right-sided (26R:12L) and measuring 18-255 mm (median 115 mm). Fourteen patients had metastatic disease at presentation. Tumour thrombus extended in the prehepatic IVC (n = 21), subdiaphragmatic IVC (n = 6) or into the SVC/right atrium (n = 3). Open adrenalectomy was associated with resection of surrounding viscera in 24 patients (nephrectomy n = 16, liver resection n = 14, splenectomy n = 3, Whipple procedure n = 2). IVC was controlled locally (n = 27), at suprahepatic levels (n = 6) or necessitated cardiac bypass (n = 5). Complete resection (R0, n = 20) was achieved in the majority of patients, with a minority having microscopic persistent disease (R1, n = 7) or macroscopic residual disease (R2, n = 4). Perioperative 30-day mortality was 13% (n = 5). Postoperative Mitotane was used in 23 patients and chemotherapy in eight patients. Twenty-five patients died 2-61 months after their operation (median 5 months). Currently, 13 patients are alive at 2-58 months (median 16 months) with known metastatic disease (n = 7) or with no signs of distant disease (n = 6). This dataset is limited by the lack of a denominator as it remains unknown how many other patients with ACC presenting with IVC invasion did not undergo surgery. The relatively low perioperative mortality and the long disease-free survival achieved by some patients should encourage surgeons with adequate experience to offer surgical treatment to patients presenting with advanced adrenocortical cancers.Keywords
This publication has 12 references indexed in Scilit:
- Adrenocortical carcinoma: The influence of large vessel extensionSurgery, 2010
- Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 PatientsEuropean Urology, 2010
- How is Adrenocortical Cancer being Managed in the UK?The Annals of The Royal College of Surgeons of England, 2009
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinomaCancer, 2009
- Adrenocortical carcinoma in the United StatesCancer, 2008
- Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress?World Journal of Surgery, 2006
- Risk Assessment in 457 Adrenal Cortical Carcinomas: How Much Does Tumor Size Predict the Likelihood of Malignancy?Journal of the American College of Surgeons, 2006
- Adrenocortical carcinoma extending into the inferior vena cava: Presentation of a 15-patient series and review of the literatureSurgery, 2006
- Adrenocortical carcinomas: surgical trends and results of a 253‐patient series from the French Association of Endocrine Surgeons study groupWorld Journal of Surgery, 2001
- Adrenocortical Carcinoma: Is Prognosis Different in Nonfunctioning Tumors? Results of Surgical Treatment in 31 PatientsWorld Journal of Surgery, 2001